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Interleukin  1 (IL-1) or lymphocyte-activating factor, a monokine released  in vitro 
by cultured monocytes or macrophages,  acts on a  variety of somatic  and immune- 
related target cells in a genetically unrestricted manner (1-5). 
It has long been recognized that fibroblasts appear at sites of inflammatory reactions 
after macrophages and play a pivotal role in the repair of damaged connective tissue 
by synthesizing and remodeling components of the matrix (e.g., collagens, fibronectin, 
and  proteoglycans)  (6).  In  this  report,  we  have  observed  that  IL-1  is  a  potent 
stimulator of fibroblast collagenase production in vitro. This finding suggests that IL- 
l  may be  a  major  effector molecule  by  which  macrophages  modulate not  only 
fibroblast growth but collagenase production  as well (4, 5). 
Materials and Methods 
IL-1 Purification.  In preliminary studies,  we found  that  IL-1 isolated from normal  human 
peripheral blood monocytes was contaminated by lymphokines (personal observation by A. E. 
Postlethwaite  and  L.  Lachman).  However,  IL-I  from  monoblasts  from  patients  with  acute 
monocytic or myelomonocytic leukemia was free of contaminating lyrnphokines and its physi- 
cochemical  properties  were  identical  to  those  of IL-1  obtained  from  normal  monocytes  (7). 
IL-1 was purified from supernatants from cultures of monoblasts by diafiltration, uhrafihration, 
and  isoelectric  focusing  (IEF)  as  previously  described  (7,  8).  The  protein  content  of IL-1 
prepared in this manner was below the limit detectable by the Lowry assay (<50 ng/ml). 
High  Performance Liquid Chromatography.  Analytical  gel  filtration  high  performance  liquid 
chromatography  (HPLC)  was  performed  on  two  1-125  protein  analysis  columns  (Waters 
Associates, Inc., Milford, MA) connected in tandem.  The columns were equilibrated and run 
with 0.0075  M  glycylglycine:0.14 M  NaCI (GGBS) at pH 7.2. 
Analytical anion exchange-HPLC was also performed on a  250-mm ×  4. l-ram SynChropak 
AX300 column (SynChrom, Inc., Linden, IN). The starting buffer was 0.02 M  Tris acetate, pH 
8, and the limiting buffer was 0.02 M  Tris acetate:0.5 M  sodium acetate, pH 8. 
Thymocyte Proliferation Assay.  IL-1  activity  was  quantitated  by  measuring  the  uptake  of 
tritiated thymidine ([3H]TdR) by thymoeytes from 6- to 10-wk-old Swiss-Webster mice (Charles 
River Breeding Laboratories, Inc., Boston, MA) (7). Standard errors were < 10% of the mean of 
triplicate determinations, 
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Fibroblast Collagenase Production.  Cultures of human infant foreskin fibroblasts or HFL-1 cells, 
an established line of human embryonic  lung fibroblasts (Cell Repository Designation, CCL153; 
American Type  Culture Collection, Rockville, MD)  were  seeded  in wells  of Falcon  3008 
muhiwell plates  (Falcon Labware,  Oxnard, CA)  and grown to confluency in maintenance 
medium (Eagle's minimum essential medium supplemented with nonessential amino acids, 50 
#g/ml  ascorbic  acid,  100  ~g/ml  streptomycin,  1 p,g/ml  amphoteracin  B,  and  10%  heat- 
inactivated fetal calf serum [Grand Island Biological Co., Grand Island, NY]) for 72 h at 37°C 
in a humidified atmosphere that contained 5% CO2. Fibroblasts were serum-starved for three 
additional days.  Medium was then removed from each well and replaced with 200/LI serum- 
free maintenance medium plus 100 #1 of sample, and the fibroblasts were cultured for 24 h. 
Harvested fibroblast culture supernatants were preincuhated with trypsin to activate latent 
collagenasc  as follows: Aliquots (200/~1) of culture supernatant were incubated at 25°C for 30 
min with  20  /~1  trypsin  (TRTPCK; Worthington Biochemical Corp.,  Freehold,  N  J),  final 
concentration 10 p.g/ml.  After incubation, trypsin was inactivated by adding a fourfold excess 
of soybean trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) in a volume of 20 VI. 
Collagenase Assay.  Collagenolytic activity in fibroblast culture supernatants was quantitated 
by  using a  modification of a  microassay previously described  by Johnson-Wint (9). The 
substrate, type I calf skin collagen, was radiolabeled with 14C acetic anhydride according to the 
method of Cawston and Barrett (10). In the original description of the microassay the collagen 
substrate was  dispensed into flat-bottomed wells of microtiter plates and allowed to dry for 
several days to form a film (9). We modified the assay by keeping the substrate in gel form. Gels 
in wells were allowed to form in a humidified atmosphere at 37°C for 24 h before the addition 
of test samples.  After the addition of samples (200 ~1), plates were incubated for 24 h at 37~C 
in a  humidified atmosphere that contained 5% CO2. An aliquot (150/~1) was  then removed 
from each well and subjected to scintillation  counting. For each assay, the total counts released 
by 100% lysis of the collagen gels by bacterial collagenase (Worthington Biochemical Corp.) 
and  the  background  counts  released  by  gels  incubated with  maintenance medium  were 
determined. 
The collagenase activity of each sample applied to each 25/~1 ~4C collagen gel was calculated 
as  follows:  percent  gel  lysis =  [(cpm  sample -  mean cpm  medium)/(mean cpm  bacterial 
collagenase -  mean cpm medium)] X  100. The standard error for gel lysis values >5% was 
<10% of the mean of triplicate determinations. 
Tritiated Amino Acid Incorporation.  In some experiments, fibroblast cultures in Falcon 3008 
muhiwell plates were pulsed for 24 h with 5 #Ci of a mixture of 3H amino acids (Amersham 
Corp., Arlington Heights, IL). Harvested culture supernatants and trypsinized cell layers were 
exposed  to cold 10% trichloroacetic acid (TCA). The precipitates were collected under suction 
on Whatman 3 MM scintillation pads  (Arthur H. Thomas Co.,  Philadelphia, PA), washed 
three times with 10 ml of cold TCA, dried, and subjected to scintillation counting. 
DNA Quantitation.  The DNA content of fibroblast monolayers was measured by the method 
of Kissane and Robins (11). 
Results 
IL-1  Stimulation  of Collagenase  Production.  Different doses of IEF-purified IL-1 were 
tested for their ability to stimulate thymocyte proliferation and fibroblast collagenase 
production  (Fig.  1).  IL-1  stimulated collagenase production at  concentrations that 
triggered thymocyte proliferation, which suggests that both cell types exhibit similar 
sensitivities to IL-I  (Fig. 1). 
Because IL-1  can stimulate the replication of subconfluent fibroblasts in vitro, it 
was essential to determine whether the increase in collagenase production induced by 
IL- 1 was accompanied by an increase in fibroblast growth (4, 5). Increased collagenase 
production by  confluent fibroblasts exposed  to  IL-1  was  not  accompanied by  an 
increase in cell  layer  DNA  (Table I).  Therefore,  IL-I  does  not  appear  to  increase 
production of eollagenase simply by stimulating fibroblast growth. 
Inhibition of fibroblast protein synthesis by cycloheximide resulted in a  loss of the 
ability of IL-1 treated fibroblasts to produce increased levels of collagenase (Table II). POSTLETHWAITE ET AL.  BRIEF  DEFINITIVE REPORT  803 
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Fto.  1.  Human  1L-1  was partially purified (diafiltration, ultrafiltration, and isoelectric focusing) 
from  supernatants  of  cultures  of  monoblasts-monocytes  from  a  patient  with  acute  monocytic 
leukemia. IL-1 was added to cultures of mouse thymocytes and foreskin fibroblasts at the dilutions 
indicated. Collagenase production by fibroblasts and thymocyte proliferation were measured. 
TABLE  I 
Effect of Interleukin  1 on DNA Content of Confluent Fibroblasts 
Collagenase activity 
Condition*  DNA per well 
Percent gel lysis 
Ug 
Fibroblasts  +  saline  1.06 ±  0.04  0.5 ± 0.3 
Fibroblasts  +  IL-I  0.94 +_ 0.03  82.3 ---  1.2 
* Foreskin  fibroblasts  at confluency in monolayer cultures were incubated for 24 h with 
and without IL-I (I:20 dilution). Collagenolytic activity was measured in 1be culture 
supernatants, and the  DNA content  of the fibroblast  monolayers was determined as 
described in Materials and Methods. 
TABLE  II 
Interleukin  1 and Fibroblast Protein Synthesz) 
Condition* 
3H amino acid incorporation  Collagenase activity 
Snpernatant  Cell  layer  Percent gel lysis 
cpm  cprn 
Fibrobtasts  +  saline  310 ±  12  435 ±  25  2 --- 0. l 
Fibroblasts  +  saline  +  30 ±  2  47 +  4  0.6 ±  0.2 
cycloheximide 
Fibroblasts  +  IL-I  257 ±  19  354 ±  17  94.8 ±  1.5 
Fibroblasts  +  IL-I +  30 __. 3  74 ±  5  0.1  ±  0.2 
cycloheximide 
* Cycloheximide (7.5/Lg/ml)  was added for 24 h to cuhures of HFL- 1 fibroblasts  with and without 
IL-I (1:20 dilution).  Trypan blue exclusion  in all cultures was >95%. All samples were added to 
sextuplet wells of Falcon  3008 multiwell plates containing PILF- 1 cells. Triplicate wells for each 
sample were pulsed  with  SH  amino acids  (see  Materials and  Methods).  Supernatants  from 
fibroblast  cultures in the remaining triplicate wells were assayed for collagenase activity. 
This suggests that protein synthesis is required for IL-1 to induce the production or 
release of collagenase from fibroblasts. 
HPLC Studies.  It was possible that IEF-purified IL-1 contained a  contaminating 
monokine that was responsible for the observed stimulation ofcollagenase production. 
In an effort to resolve this issue, IEF-purified IL-1 was subjected to further analysis by 
high  resolution  gel  filtration-  and  anion exchange-HPLC. Eluted  column fractions 80 
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FIe.  2.  A  sample (0.3 ml) of IEF-purified IL-I was applied to two I  125 protein analysis columns 
connected in tandem. Columns were run at a  flow rate of 1 ml/min  as described in  Materials and 
Methods.  Fractions (0.4  m[)  were collected and  tested at a  1:6 dilution for their effect on  foreskin 
fibroblast collagenase production and thymocyte proliferation, 
were  tested  for  their  ability  to  stimulate  fibroblast  collagenase  production  and 
thymocyte proliferation. When IEF-purified IL-1 was fractionated on the gel filtra- 
tion-HPLC  columns,  fractions  containing  maximal  IL-1  activity  also  stimulated 
fibroblast collagenase production (Fig. 2). The two activities were superimposable on 
the chromatogram as a single major peak (Fig. 2). 
IEF-purified  IL-1  also  eluted  from the  ion  exchange-HPLC column  as  a  single 
major peak between 21 and 27% of the salt gradient (Fig. 3). Fractions that stimulated 
fibroblast collagenase production eluted in the same region of the gradient  (Fig. 3). 
Taken together, these HPLC data indicate that IL-1 possesses  the ability to stimulate 
fibroblast collagenase production. 
Discussion 
Human IL-1 stimulates collagenase production by fibroblasts in a dose-dependent 
manner.  Analysis of IEF-purified IL-1  by high  resolution gel  filtration- and  anion 
exehange-HPLC revealed that  thymocyte proliferation and  fibroblast collagenase- 
stimulating activities could not be dissociated. These data indicate that human IL-1 
possesses,  in addition to its previously recognized properties, the ability to enhance 
coltagenase production by connective tissue fibroblasts. 
It should be noted that  IL-1  from the murine macrophage cell line P388D1  has 
been shown to be capable of stimulating collagenase production by adherent rheu- 
matoid synovial cells, and that a human mononuclear cell factor previously recognized 
to have the same effect on synovial cells has some properties in common with IL-1 
obtained from the P388D1 cell line (3, 12-!4). Adherent rheumatoid synovial cells are POSTLETHWAITE  ET  AL.  BRIEF  DEFINITIVE  REPORT  805 
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FIG.  3.  A  sample  (0.3  ml)  of IEF-purified IL-I  was  applied  to  a  SynChropak AX300  anion- 
exchange column and eluted with a linear salt gradient at a  flow rate of 1 ml/min as described in 
Materials and  Methods.  Fractions  (0.5  ml)  were collected and  tested  at  a  1:6  dilution for their 
ability to stimulate HFL-1  fibroblast eollagenase production and thymocyte proliferation. 
morphologically  and  functionally  different  from  connective  tissue  fibroblasts  (e.g., 
more heterogeneous, larger, and they produce more collagenase and less collagen than 
fibroblasts),  and their true nature and origin remain to be defined  (3). In addition, 
IL-1  from  P388D1  cells  is chemically  and physically different  from  human IL-1, as 
evidenced by the fact that their isoelectric points and protease sensitivities are not the 
same  (7, 8,  15,  16). 
Because a  variety of different  substances  (e.g., antigen-antibody complexes,  phag- 
ocytized  particles,  antigen-  or  mitogen-stimulated  lymphocytes,  lymphokines,  and 
microbial-derived  components)  have been  reported  to stimulate  the release  of IL-1 
from macrophages in vitro, it is conceivable that IL-1 could be released by monocytes- 
macrophages  at  sites  of inflammatory  reactions  of diverse  etiologies  (1).  IL-1  may 
serve  an  important  role  in  regulating  collagenase  production  by  fibroblasts  and 
thereby influence the remodeling of collagen at sites of inflammation in vivo. 
Summary 
Interleukin  1 is a monokine that exerts biological effects on a variety of target cells 
in  vitro.  In  this report,  interleukin  1 has  been  found  to  be  capable  of stimulating 
collagenase production by cultured dermal  fibroblasts.  The concentrations of inter- 
leukin  1 that  stimulate  fibroblast  collagenase  production  are  similar  to  those  that 
stimulate mouse thymocyte proliferation. Analyses by high performance liquid chro- 
matography  indicate that  interleukin  l,  rather  than a  contaminating  monokine,  is 806  POSTLETHWAITE ET  AL.  BRIEF DEFINITIVE REPORT 
responsible for this effect on fibroblasts. Interleukin 1, released in vivo by macrophages 
infiltrating sites of tissue  damage  or  inflammation,  may  function  to  stimulate  the 
release of collagenase by connective tissue fibroblasts. 
The authors acknowledge the excellent technical assistance of Susan Turner, Elizabeth Schaef- 
fer, and  Cynthia Carter,  and  the secretarial assistance of Dorothy K.  Davis. The  technical 
suggestions by Dr. Jerome M. Seyer were most useful in carrying out HPLC analyses. 
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